J Filderman
Impact in
- Immunology top 10%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- interferon and immune responses 4
- Immunotherapy and Immune Responses 2
- Immune cells in cancer 2
- Galectins and Cancer Biology 1
- Toxin Mechanisms and Immunotoxins 1
- Immune Response and Inflammation 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Walter J. Storkus (5 shared papers)Manoj Chelvanambi (2 shared papers)Afsaneh Amouzegar (1 shared paper)Jason J. Luke (1 shared paper)Andrea L. Szymczak-Workman (1 shared paper)Lyndsay Avery (1 shared paper)Larry Kane (1 shared paper)Yariv Mazor (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Cancers (1 paper)The Journal of Immunology (1 paper)Scientific Reports (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesJordan
In The Last Decade
J Filderman
7 papers receiving 519 citations
J Filderman's Hit Papers
Peers
Comparison fields: 5 of 44
- Immunology 411
- Oncology 234
- Infectious Diseases 77
- Radiology, Nuclear Medicine and Imaging 87
- Molecular Biology 191
Countries citing papers authored by J Filderman
This map shows the geographic impact of J Filderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Filderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Filderman more than expected).
Fields of papers citing papers by J Filderman
This network shows the impact of papers produced by J Filderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Filderman. The network helps show where J Filderman may publish in the future.
Co-authors
The 25 scholars most cited alongside J Filderman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | STING Agonists as Cancer Therapeutics Hit paper breakdown → | 2021 | 286 |
| 2 | 2018 | 121 | |
| 3 | 2017 | 89 | |
| 4 | 2021 | 29 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 1 |
About J Filderman
J Filderman is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 7 papers that have together received 532 indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers), Signaling Pathways in Disease (1 paper), Galectins and Cancer Biology (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Immunology (411 citations), Oncology (234 citations), Infectious Diseases (77 citations), Radiology, Nuclear Medicine and Imaging (87 citations) and Molecular Biology (191 citations). J Filderman has collaborated with scholars based in United States and Jordan. Frequent co-authors include Walter J. Storkus, Manoj Chelvanambi, Afsaneh Amouzegar, Jason J. Luke, Andrea L. Szymczak-Workman, Lyndsay Avery, Larry Kane, Yariv Mazor, Chunning Yang and Herren Wu. Their work appears in journals such as Frontiers in Immunology, Cancers, The Journal of Immunology, Scientific Reports and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.